Encapsulating peritoneal sclerosis: the state of affairs (Q95361164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

review article

1 reference

title

Encapsulating peritoneal sclerosis: the state of affairs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

author name string

Mario R Korte

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

Denise E Sampimon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

Raymond T Krediet

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

publication date

2 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

24 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

page(s)

528-538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

Encapsulating peritoneal sclerosis in the new millennium: a national cohort study

24 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing peritonitis: the experience in Australia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The transport barrier in intraperitoneal therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The natural course of peritoneal membrane biology during peritoneal dialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Prevention and treatment of acute renal failure in sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Different aspects of peritoneal damage: fibrosis and sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

PERITONEAL PERMEABILITY AND ENCAPSULATING PERITONITIS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Growth factors VEGF and TGF-beta1 in peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Smad3-dependent and -independent pathways are involved in peritoneal membrane injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Transforming growth factor beta in tissue fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Myofibroblastic conversion of mesothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Lens-specific expression of TGF-beta induces anterior subcapsular cataract formation in the absence of Smad3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Encapsulating peritoneal sclerosis: clinical significance and implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Encapsulating peritoneal sclerosis in a peritoneal dialysis patient using biocompatible fluids only: is Alport syndrome a risk factor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Peritoneal dialysis complicated by fungal peritonitis and peritoneal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Corticosteroid therapy in encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing encapsulating peritonitis in a liver transplant patient: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing encapsulating peritonitis in chronic ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

The imaging diagnosis of sclerosing peritonitis (SP) following continuous ambulatory peritoneal dialysis (CAPD)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing Peritonitis: Identification of Diagnostic, Clinical, and Radiological Features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

CT appearance of sclerosing peritonitis in patients on chronic ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Clinical images: Encapsulating peritoneal sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Sclerosing encapsulating peritonitis: MRI diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Limitations of CA125 as an index of peritoneal mesothelial cell mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Immunosuppressive treatment for sclerosing peritonitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Use of angiotensin II inhibitors in patients that develop encapsulating peritoneal sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.93

Effluent hydroxyproline in experimental peritoneal dialysis

31 March 2020

1 reference

12 December 2020

Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis

1 reference

12 December 2020

The difference in causes of early and late ultrafiltration failure in peritoneal dialysis.

1 reference

12 December 2020

An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now.

1 reference

12 December 2020

The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis

1 reference

12 December 2020

Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis

1 reference

12 December 2020

Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.

1 reference

12 December 2020

Immunosuppression in sclerosing peritonitis

1 reference

12 December 2020

Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone.

1 reference

12 December 2020

Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function.

1 reference

12 December 2020

Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.

1 reference

12 December 2020

Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution

1 reference

12 December 2020

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen

1 reference

12 December 2020

Angiotensin II as a renal growth factor

1 reference

12 December 2020

Dialysate CA125 in stable CAPD patients: no relation with transport parameters

1 reference

12 December 2020

Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts.

1 reference

12 December 2020

Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.

1 reference

12 December 2020

Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.

1 reference

12 December 2020

The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.

1 reference

12 December 2020

Successful surgical management of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis.

1 reference

12 December 2020

Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis.

1 reference

12 December 2020

Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery

1 reference

12 December 2020

Posttransplant encapsulating peritoneal sclerosis: a worrying new trend?

1 reference

12 December 2020

European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions

1 reference

12 December 2020

Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?

1 reference

12 December 2020

Case-control study to determine the cause of sclerosing peritoneal disease.

1 reference

12 December 2020

Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis

1 reference

12 December 2020

Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients

1 reference

12 December 2020

Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions

1 reference

12 December 2020

Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002.

1 reference

12 December 2020

Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure

1 reference

12 December 2020

The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics

1 reference

12 December 2020

Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species.

1 reference

12 December 2020

Correlation between peritoneal equilibration test and dialysis adequacy and transport test, for peritoneal transport type characterization. Mexican Nephrology Collaborative Study Group

1 reference

12 December 2020

Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells

1 reference

12 December 2020

Prolonged peritoneal gene expression using a helper-dependent adenovirus.

1 reference

12 December 2020

Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment

1 reference

12 December 2020

Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis

1 reference

12 December 2020

Morphologic changes in the peritoneal membrane of patients with renal disease

1 reference

12 December 2020

Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis

1 reference

12 December 2020

Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane.

1 reference

12 December 2020

Sclerosing peritonitis: value of immunosuppression prior to surgery

1 reference

12 December 2020

Peritoneal and systemic inflammation: the benefits of using biocompatible peritoneal dialysis fluids

1 reference

12 December 2020

Peritoneal accumulation of AGE and peritoneal membrane permeability

1 reference

12 December 2020

Pathology of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen.

1 reference

12 December 2020

Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study

1 reference

12 December 2020

Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients

1 reference

12 December 2020

Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?

1 reference

12 December 2020

Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.

1 reference

12 December 2020

Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study.

1 reference

12 December 2020

A new model of anterior subcapsular cataract: involvement of TGFbeta/Smad signaling.

1 reference

12 December 2020

How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis?

1 reference

12 December 2020

Sclerosing peritonitis: a nosological entity

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21808281%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1 reference